.jpg "Government Demands 1 year Residual Shell Life for Imported Drugs")
A new rule comes into line for expanding the residual shell life of imported drugs in India,amid the wastage of medicines and the capital loss in operation and supply chain management
Alembic Pharma has gained entry into the USD 27 million US flu drug market after receiving USFDA approval for its generic flu drug, Oseltamivir Phosphate for Oral Suspension.
A packaging loophole allegedly helped counterfeit medicines enter global markets using genuine-looking pharmaceutical packaging.
Air Suvidha 2.0 is now mandatory for all international passengers arriving in India as the government steps up airport health screening amid the ongoing Ebola outbreak in parts of Africa.
Patients with rare cancer mutations in India now have access to a globally approved treatment option. Tanstrive, a targeted cancer therapy from Eli Lilly, has been launched in the country for patients with RET-altered tumors.
India’s Blood Standards Could Transform Patient Safety as India becomes the first country in the world to introduce exclusive standards for blood and blood components under the Indian Pharmacopoeia 2026.
As the miracle drug cure for cancer Keytruda nears expiry almost seven Indian manufacturers are set on a race to develop generic versions of the drug.
Ebola cases have crossed the 1,000 mark in Central Africa, prompting a fresh warning from the World Health Organization (WHO).
India gets a rare end-to-end ADC manufacturing facility as Shilpa Biologicals, a material subsidiary of Shilpa Medicare, commissioned one of the country’s few fully integrated Antibody-Drug Conjugate (ADC) manufacturing plants.
Translational Research could be the key to unlocking the next phase of growth for India's pharmaceutical sector, according to a new white paper that highlights major gaps in the country's innovation ecosystem.
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")